KNW icon

Know Labs

0.1431 USD
-0.0082
5.42%
At close Dec 20, 4:00 PM EST
After hours
0.1500
+0.0069
4.82%
1 day
-5.42%
5 days
-33.10%
1 month
-37.84%
3 months
-47.85%
6 months
-72.48%
Year to date
-73.23%
1 year
-75.75%
5 years
-93.19%
10 years
-93.19%
 

About: Know Labs Inc is a medical diagnostic. The company is focused on the development, marketing, and sales of proprietary technologies that are capable of uniquely identifying or authenticating almost any substance or material using electromagnetic energy to record, detect, and identify the signature of the substance or material known as Bio-RFID and ChromaID technologies. It is developing a wearable device that will measure blood glucose without fingersticks or microneedles.

Employees: 12

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

3% more funds holding

Funds holding: 31 [Q2] → 32 (+1) [Q3]

1.92% less ownership

Funds ownership: 5.5% [Q2] → 3.58% (-1.92%) [Q3]

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

44% less capital invested

Capital invested by funds: $1.93M [Q2] → $1.09M (-$842K) [Q3]

Research analyst outlook

We haven’t received any recent analyst ratings for KNW.

Financial journalist opinion

Neutral
Business Wire
1 week ago
Know Labs, Inc. Announces $300K Registered Direct Offering
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. Announces $300K Registered Direct Offering.
Know Labs, Inc. Announces $300K Registered Direct Offering
Neutral
Business Wire
1 week ago
Know Labs, Inc. Announces NYSE American Acceptance of Plan to Regain Compliance
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. Announces NYSE American Acceptance of Plan to Regain Compliance with the listing standards.
Know Labs, Inc. Announces NYSE American Acceptance of Plan to Regain Compliance
Neutral
Business Wire
1 month ago
Know Labs Provides Overview of FY2024 10-K Annual Report
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive diagnostics technology released this morning an overview of its Form 10-K annual report for its fiscal year ending September 30, 2024, and provided reassurance regarding its progress over the past year, its plans and the state of its financial stability in light of its auditor required going concern opinion. Know Labs (the “Company”) issued a press release on November 15, 2024, regarding the rece.
Know Labs Provides Overview of FY2024 10-K Annual Report
Neutral
Business Wire
1 month ago
Know Labs, Inc. Announces Receipt of Audit Opinion with Going Concern Explanation
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), leading developer of non-invasive diagnostics technology, today announced that, as previously disclosed in its Annual Report on Form 10-K for the year ended September 30, 2024, which was filed on November 14, 2024 with the Securities and Exchange Commission, the audited financial statements contained an audit opinion from its independent registered public accounting firm that included an explanatory paragraph related to the Company.
Know Labs, Inc. Announces Receipt of Audit Opinion with Going Concern Explanation
Neutral
Business Wire
1 month ago
Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2024 Results
SEATTLE--(BUSINESS WIRE)--Know Labs, an emerging developer of non-invasive medical diagnostic technology, reported financial results for the Q4 and fiscal year of 2024.
Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2024 Results
Neutral
Business Wire
1 month ago
Know Labs Announces Expanded Technology Leadership in its Executive Team
SEATTLE--(BUSINESS WIRE)--Know Labs Announces Expanded Technology Leadership in its Executive Team; Acceleration of Platform Development to Secure Strategic Partnerships.
Know Labs Announces Expanded Technology Leadership in its Executive Team
Neutral
Business Wire
2 months ago
Know Labs Sensor Technology in Steering Wheels Could Curb Impaired Driving
SEATTLE--(BUSINESS WIRE)--Know Labs Sensor Technology in Steering Wheels Could Curb Impaired Driving. Know Labs Retains Stanbridge Group to Secure Automotive JV Partnerships.
Know Labs Sensor Technology in Steering Wheels Could Curb Impaired Driving
Neutral
Business Wire
2 months ago
Know Labs Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
SEATTLE--(BUSINESS WIRE)--Know Labs Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards. A Plan for Compliance has been undertaken.
Know Labs Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
Neutral
Seeking Alpha
4 months ago
Know Labs, Inc. (KNW) Q3 2024 Earnings Call Transcript
Know Labs, Inc. (NYSE:KNW ) Q3 2024 Results Earnings Conference Call August 14, 2024 4:30 PM ET Company Participants Ron Erickson - Chairman and Chief Executive Officer Peter Conley - Chief Financial Officer and Senior Vice President, IP Conference Call Participants Operator Greetings. Welcome to Know Labs's Third Quarter 2024 Earnings Conference Call.
Know Labs, Inc. (KNW) Q3 2024 Earnings Call Transcript
Neutral
Business Wire
4 months ago
Know Labs, Inc. Reports Third Quarter FY 2024 Results
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today reported financial results for the third quarter of the fiscal year 2024 ended June 30, 2024. Financial Highlights: In Q3 FY 2024, Know Labs reported a net loss of $4.10 million dollars, compared to a net loss of $3.60 million dollars in Q3 FY 2023, an increase in net loss of 13.9%. This translates to earnings per share of a loss of $0.05, better than the prio.
Know Labs, Inc. Reports Third Quarter FY 2024 Results
Charts implemented using Lightweight Charts™